Vnitr Lek 2014, 60(5-6):458-461

Live style and risk of lifestyle diseases

Jan Kábrt
Klinika Program H plus Praha, ředitelka společnosti Monika Šubrtová

Metabolic syndrome included obesity, diabetes mellitus type II, hypertension and disorder of lipid metabolism are serious complication affecting many people of economic advanced countries. Unhealthy live style with limited physical activity and overfeeding are the main cause of this disorder. Adjustment of the live style with regular physical activity has the better result compared with a diet intervention alone.

Keywords: abdominal obesity; live style; metabolic syndrome; physical activity

Received: March 13, 2014; Published: May 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kábrt J. Live style and risk of lifestyle diseases. Vnitr Lek. 2014;60(5-6):458-461.
Download citation

References

  1. DeFronzo RA, Ferrannini E. Insulin resistence: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes care 1991; 14(3): 173-194. Go to original source... Go to PubMed...
  2. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceredemia and hypertension. Arch Intern Med 1989; 149(7): 1514-1520. Go to original source...
  3. Reaven GM. Role of insulin resistence in human disease. Diabetes 1988; 37(12): 1595-1607. Go to original source... Go to PubMed...
  4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA 2001; 285(19): 2486-2497. Go to original source... Go to PubMed...
  5. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14: 353-362.
  6. Svobodová Š, Topolčan O. Metabolický syndrom, predikce a prevence. Interní Med 2012; 14(11): 412-414.
  7. Šobra J. Proč zbytečně umíráme : esej o současném člověku v epidemii srdečně-cévních onemocnění, která chce oslovit ty, jež chtějí vědět. Radix: Praha 1996. ISBN 80-86031-06-3.
  8. The Framingham Offspring Study: a commentary. 1980. JACC 1999; 33(5): 1136-1140.
  9. Matoulek M, Svačina Š, Lajka J. Výskyt obezity a přidružených onemocnění v ČR. Vnitř Lék 2010; 56(10): 1019-1027. Go to PubMed...
  10. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92(3): 347-355. Go to original source... Go to PubMed...
  11. Browning ID, Szczenaniak IS et al. Prevalance of hepatis steatosis in an urban population in the United States. Impact of etnicity. Hepatology 2004; 40(6):1387-1395. Go to original source... Go to PubMed...
  12. Zimmet PZ, Alberti KG, Shaw JE. Mainstreaming the metabolic syndrome: a definite definition. Med J Aust 2005; 15: 183(4): 175-176. Go to original source... Go to PubMed...
  13. Orchard TJ, Temprosa M et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Preventive Program randomized trial. Ann Intern Med 2005; 142(8): 611-619. Go to original source... Go to PubMed...
  14. Yamaoka J, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012; 10: 138. Dostupné z DOI: <http://doi:10.1186/1741-7015-10-138>. Go to original source... Go to PubMed...
  15. Svačina Š et al. Metabolický syndrom. Grada Publishing: Praha 2011. ISBN 978-80-247-4092-8.
  16. Doležalová R, Haluzík M. Metabolický syndrom a fyzická aktivita. In: Svačina Š (ed). Trendy soudobé diabetologie. Galén: Praha 2005. ISBN 80-7262-359-1.
  17. Collins F. Řeč života. Academia: Praha 2012. ISBN 978-80-200-2161-8.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.